Physician profile
Peter K Caviris
NPI 1003959594
$328.03
in general payments reported to CMS, 2019-2025
6 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.63 · 2020: $13.62 · 2022: $50.00 · 2023: $99.78 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $137 · Education: $50.00 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44.61 · Food and Beverage: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $137.00 |
| Education | $50.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44.61 |
| Food and Beverage | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply LLC | $137.00 | 2025 | |
| Straumann USA LLC | $100.00 | 2022-2023 | |
| Septodont INC. | $44.61 | 2023 | Bioroot Flow (Sample) |
| Dmg America LLC | $27.63 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $13.62 | 2020 | |
| Biolase, INC. | $5.17 | 2023 | Waterlase Iplus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Caviris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.